Symbol:
Slc12a7
Name:
solute carrier family 12 member 7
RGD ID:
1359672
Description:
Predicted to enable potassium:chloride symporter activity and protein kinase binding activity. Involved in cell volume homeostasis. Predicted to be located in membrane and synapse. Predicted to be part of protein-containing complex. Predicted to be active in plasma membrane. Orthologous to human SLC12A7 (solute carrier family 12 member 7); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,4-dinitrotoluene; 2,6-dinitrotoluene.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
electroneutral potassium-chloride cotransporter 4; furosemide-sensitive KCl cotransporter 4; K-Cl cotransporter 4; K-Cl cotransporter KCC4; Kcc4; LOC308069; solute carrier family 12 (potassium/chloride transporter), member 7; solute carrier family 12 (potassium/chloride transporters), member 7; solute carrier family 12, member 7
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
SLC12A7 (solute carrier family 12 member 7)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Slc12a7 (solute carrier family 12, member 7)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Slc12a7 (solute carrier family 12 member 7)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
SLC12A7 (solute carrier family 12 member 7)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
SLC12A7 (solute carrier family 12 member 7)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Slc12a7 (solute carrier family 12 member 7)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
SLC12A7 (solute carrier family 12 member 7)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
SLC12A7 (solute carrier family 12 member 7)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Slc12a7 (solute carrier family 12 member 7)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
SLC12A5 (solute carrier family 12 member 5)
HGNC
OrthoDB
Homo sapiens (human):
OR2W3 (olfactory receptor family 2 subfamily W member 3)
HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
SLC12A7 (solute carrier family 12 member 7)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Slc12a7 (solute carrier family 12, member 7)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
slc12a7b (solute carrier family 12 member 7b)
Alliance
DIOPT (Ensembl Compara|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
slc12a7a (solute carrier family 12 member 7a)
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER|PhylomeDB)
Drosophila melanogaster (fruit fly):
kcc
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
kcc-2
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 31,301,243 - 31,382,825 (-) NCBI GRCr8 mRatBN7.2 1 29,472,692 - 29,554,246 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 29,472,692 - 29,554,302 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 29,273,827 - 29,327,212 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 35,273,677 - 35,327,062 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 29,474,455 - 29,527,840 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 32,086,755 - 32,167,950 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 32,086,755 - 32,141,036 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 33,511,432 - 33,592,624 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 30,281,826 - 30,334,183 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 30,283,750 - 30,337,129 (-) NCBI Celera 1 28,120,766 - 28,174,109 (-) NCBI Celera Cytogenetic Map 1 p11 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Slc12a7 Rat 1,2-dimethylhydrazine multiple interactions ISO RGD:1550903 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC12A7 mRNA CTD PMID:22206623 Slc12a7 Rat 1-Hydroxypyrene decreases expression ISO RGD:1348814 6480464 1-hydroxypyrene results in decreased expression of SLC12A7 mRNA CTD PMID:21854004 Slc12a7 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC12A7 mRNA CTD PMID:16960034 Slc12a7 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1550903 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC12A7 mRNA CTD PMID:16960034|PMID:21496263 Slc12a7 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1348814 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC12A7 mRNA CTD PMID:19684285|PMID:20106945|PMID:21496263|PMID:21632981 Slc12a7 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550903 6480464 Tetrachlorodibenzodioxin affects the expression of SLC12A7 mRNA CTD PMID:21570461 Slc12a7 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1348814 6480464 Tetrachlorodibenzodioxin affects the expression of SLC12A7 mRNA CTD PMID:22298810 Slc12a7 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC12A7 mRNA CTD PMID:19692669 Slc12a7 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1550903 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC12A7 mRNA CTD PMID:19684285 Slc12a7 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2,4-dinitrotoluene affects the expression of SLC12A7 mRNA CTD PMID:21346803 Slc12a7 Rat 2,6-dinitrotoluene affects expression EXP 6480464 2,6-dinitrotoluene affects the expression of SLC12A7 mRNA CTD PMID:21346803 Slc12a7 Rat 2-palmitoylglycerol increases expression ISO RGD:1348814 6480464 2-palmitoylglycerol results in increased expression of SLC12A7 mRNA CTD PMID:37199045 Slc12a7 Rat 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid decreases activity ISO RGD:1550903 6480464 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid results in decreased activity of SLC12A7 protein CTD PMID:10913127 Slc12a7 Rat 4-hydroxyphenyl retinamide increases expression ISO RGD:1550903 6480464 Fenretinide results in increased expression of SLC12A7 mRNA CTD PMID:28973697 Slc12a7 Rat 4-tert-Octylphenol increases expression EXP 6480464 4-tert-octylphenol results in increased expression of SLC12A7 mRNA CTD PMID:17011747 Slc12a7 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC12A7 mRNA CTD PMID:24780913 Slc12a7 Rat amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of SLC12A7 mRNA CTD PMID:30779732 Slc12a7 Rat antirheumatic drug decreases expression ISO RGD:1348814 6480464 Antirheumatic Agents results in decreased expression of SLC12A7 mRNA CTD PMID:24449571 Slc12a7 Rat arsane affects methylation ISO RGD:1348814 6480464 Arsenic affects the methylation of SLC12A7 gene CTD PMID:25304211 Slc12a7 Rat arsenic atom affects methylation ISO RGD:1348814 6480464 Arsenic affects the methylation of SLC12A7 gene CTD PMID:25304211 Slc12a7 Rat atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of SLC12A7 mRNA CTD PMID:36841081 Slc12a7 Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SLC12A7 gene CTD PMID:35440735 Slc12a7 Rat Azoxymethane multiple interactions ISO RGD:1550903 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC12A7 more ... CTD PMID:29950665 Slc12a7 Rat barium(0) decreases activity ISO RGD:1550903 6480464 Barium results in decreased activity of SLC12A7 protein CTD PMID:10913127 Slc12a7 Rat benzo[a]pyrene multiple interactions ISO RGD:1550903 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to SLC12A7 promoter] CTD PMID:19654925 Slc12a7 Rat benzo[a]pyrene increases methylation ISO RGD:1348814 6480464 Benzo(a)pyrene results in increased methylation of SLC12A7 exon CTD PMID:27901495 Slc12a7 Rat benzo[a]pyrene affects methylation ISO RGD:1348814 6480464 Benzo(a)pyrene affects the methylation of SLC12A7 promoter CTD PMID:27901495 Slc12a7 Rat benzo[a]pyrene decreases methylation ISO RGD:1348814 6480464 Benzo(a)pyrene results in decreased methylation of SLC12A7 3' UTR CTD PMID:27901495 Slc12a7 Rat beta-lapachone decreases expression ISO RGD:1348814 6480464 beta-lapachone results in decreased expression of SLC12A7 mRNA CTD PMID:38218311 Slc12a7 Rat bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1550903 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Slc12a7 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC12A7 mRNA CTD PMID:25181051 Slc12a7 Rat bisphenol A affects methylation ISO RGD:1348814 6480464 bisphenol A affects the methylation of SLC12A7 gene CTD PMID:31601247 Slc12a7 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SLC12A7 gene CTD PMID:28505145 Slc12a7 Rat bisphenol F decreases expression ISO RGD:1550903 6480464 bisphenol F results in decreased expression of SLC12A7 mRNA CTD PMID:38685157 Slc12a7 Rat bumetanide decreases activity ISO RGD:1550903 6480464 Bumetanide results in decreased activity of SLC12A7 protein CTD PMID:10913127 Slc12a7 Rat Butylbenzyl phthalate multiple interactions ISO RGD:1550903 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Slc12a7 Rat C60 fullerene affects expression EXP 6480464 fullerene C60 affects the expression of SLC12A7 mRNA CTD PMID:19167457 Slc12a7 Rat cadmium dichloride increases expression ISO RGD:1348814 6480464 Cadmium Chloride results in increased expression of SLC12A7 mRNA CTD PMID:38568856 Slc12a7 Rat chromium(6+) affects expression ISO RGD:1550903 6480464 chromium hexavalent ion affects the expression of SLC12A7 mRNA CTD PMID:28472532 Slc12a7 Rat cisplatin multiple interactions ISO RGD:1348814 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SLC12A7 mRNA CTD PMID:27392435 Slc12a7 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of SLC12A7 mRNA CTD PMID:27523638 Slc12a7 Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of SLC12A7 mRNA CTD PMID:26577399 Slc12a7 Rat cyclosporin A increases expression ISO RGD:1348814 6480464 Cyclosporine results in increased expression of SLC12A7 mRNA CTD PMID:20106945 Slc12a7 Rat cyclosporin A decreases methylation ISO RGD:1348814 6480464 Cyclosporine results in decreased methylation of SLC12A7 promoter CTD PMID:27989131 Slc12a7 Rat dextran sulfate multiple interactions ISO RGD:1550903 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC12A7 more ... CTD PMID:29950665 Slc12a7 Rat diazinon increases methylation ISO RGD:1348814 6480464 Diazinon results in increased methylation of SLC12A7 gene CTD PMID:22964155 Slc12a7 Rat dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SLC12A7 mRNA CTD PMID:21266533 Slc12a7 Rat dibutyl phthalate multiple interactions ISO RGD:1550903 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Slc12a7 Rat diethyl phthalate multiple interactions ISO RGD:1550903 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Slc12a7 Rat diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of SLC12A7 mRNA CTD PMID:17011747 Slc12a7 Rat diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of SLC12A7 mRNA CTD PMID:21658437 Slc12a7 Rat diisobutyl phthalate multiple interactions ISO RGD:1550903 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Slc12a7 Rat diisononyl phthalate multiple interactions ISO RGD:1550903 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated more ... CTD PMID:39150890 Slc12a7 Rat dorsomorphin multiple interactions ISO RGD:1348814 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Slc12a7 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SLC12A7 mRNA CTD PMID:29391264 Slc12a7 Rat epoxiconazole decreases expression ISO RGD:1550903 6480464 epoxiconazole results in decreased expression of SLC12A7 mRNA CTD PMID:35436446 Slc12a7 Rat ethanol increases expression ISO RGD:1550903 6480464 Ethanol results in increased expression of SLC12A7 mRNA CTD PMID:30319688 Slc12a7 Rat fenamidone increases expression ISO RGD:1550903 6480464 fenamidone results in increased expression of SLC12A7 mRNA CTD PMID:27029645 Slc12a7 Rat fipronil increases expression EXP 6480464 fipronil results in increased expression of SLC12A7 mRNA CTD PMID:34044035 Slc12a7 Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC12A7 mRNA CTD PMID:24136188 Slc12a7 Rat folic acid multiple interactions ISO RGD:1550903 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC12A7 mRNA CTD PMID:22206623 Slc12a7 Rat FR900359 affects phosphorylation ISO RGD:1348814 6480464 FR900359 affects the phosphorylation of SLC12A7 protein CTD PMID:37730182 Slc12a7 Rat furosemide decreases activity ISO RGD:1550903 6480464 Furosemide results in decreased activity of SLC12A7 protein CTD PMID:10913127 Slc12a7 Rat hydrogen cyanide decreases expression ISO RGD:1550903 6480464 Hydrogen Cyanide results in decreased expression of SLC12A7 mRNA CTD PMID:33914522 Slc12a7 Rat leflunomide increases expression ISO RGD:1348814 6480464 leflunomide results in increased expression of SLC12A7 mRNA CTD PMID:28988120 Slc12a7 Rat Licochalcone B decreases expression ISO RGD:1348814 6480464 licochalcone B results in decreased expression of SLC12A7 mRNA CTD PMID:33647349 Slc12a7 Rat menadione affects expression ISO RGD:1348814 6480464 Vitamin K 3 affects the expression of SLC12A7 mRNA CTD PMID:20044591 Slc12a7 Rat methotrexate decreases expression ISO RGD:1348814 6480464 Methotrexate results in decreased expression of SLC12A7 mRNA CTD PMID:24449571 Slc12a7 Rat N-methyl-4-phenylpyridinium increases expression ISO RGD:1348814 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC12A7 mRNA CTD PMID:24810058 Slc12a7 Rat nickel sulfate increases expression ISO RGD:1348814 6480464 nickel sulfate results in increased expression of SLC12A7 mRNA CTD PMID:22714537 Slc12a7 Rat okadaic acid increases expression ISO RGD:1348814 6480464 Okadaic Acid results in increased expression of SLC12A7 mRNA CTD PMID:38832940 Slc12a7 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC12A7 mRNA CTD PMID:25729387 Slc12a7 Rat p-tert-Amylphenol increases expression EXP 6480464 4-tert-octylphenol results in increased expression of SLC12A7 mRNA CTD PMID:17011747 Slc12a7 Rat paracetamol affects expression ISO RGD:1550903 6480464 Acetaminophen affects the expression of SLC12A7 mRNA CTD PMID:17562736 Slc12a7 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC12A7 mRNA CTD PMID:33387578 Slc12a7 Rat perfluorohexanesulfonic acid decreases expression ISO RGD:1550903 6480464 perfluorohexanesulfonic acid results in decreased expression of SLC12A7 mRNA CTD PMID:37995155 Slc12a7 Rat pirinixic acid decreases expression ISO RGD:1550903 6480464 pirinixic acid results in decreased expression of SLC12A7 mRNA CTD PMID:18445702 Slc12a7 Rat pirinixic acid increases expression ISO RGD:1550903 6480464 pirinixic acid results in increased expression of SLC12A7 mRNA CTD PMID:18301758 Slc12a7 Rat potassium cyanide decreases expression ISO RGD:1550903 6480464 Potassium Cyanide results in decreased expression of SLC12A7 mRNA CTD PMID:33914522 Slc12a7 Rat pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of SLC12A7 mRNA CTD PMID:19162173 Slc12a7 Rat propiconazole decreases expression ISO RGD:1550903 6480464 propiconazole results in decreased expression of SLC12A7 mRNA CTD PMID:21278054 Slc12a7 Rat resveratrol increases expression ISO RGD:1550903 6480464 resveratrol results in increased expression of SLC12A7 protein CTD PMID:25505154 Slc12a7 Rat rotenone increases expression ISO RGD:1348814 6480464 Rotenone results in increased expression of SLC12A7 mRNA CTD PMID:29955902 Slc12a7 Rat SB 431542 multiple interactions ISO RGD:1348814 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Slc12a7 Rat silicon dioxide increases expression ISO RGD:1348814 6480464 Silicon Dioxide results in increased expression of SLC12A7 mRNA CTD PMID:25351596 Slc12a7 Rat sulforaphane increases expression ISO RGD:1348814 6480464 sulforaphane results in increased expression of SLC12A7 mRNA CTD PMID:31838189 Slc12a7 Rat sunitinib decreases expression ISO RGD:1348814 6480464 Sunitinib results in decreased expression of SLC12A7 mRNA CTD PMID:31533062 Slc12a7 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC12A7 mRNA CTD PMID:31150632 Slc12a7 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC12A7 mRNA CTD PMID:34492290 Slc12a7 Rat titanium dioxide multiple interactions ISO RGD:1550903 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC12A7 more ... CTD PMID:29950665 Slc12a7 Rat titanium dioxide decreases methylation ISO RGD:1550903 6480464 titanium dioxide results in decreased methylation of SLC12A7 gene; titanium dioxide results in decreased methylation more ... CTD PMID:35295148 Slc12a7 Rat topotecan increases expression EXP 6480464 Topotecan results in increased expression of SLC12A7 mRNA CTD PMID:25729387 Slc12a7 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC12A7 mRNA CTD PMID:25729387 Slc12a7 Rat trichlormethiazide decreases activity ISO RGD:1550903 6480464 Trichlormethiazide results in decreased activity of SLC12A7 protein CTD PMID:10913127 Slc12a7 Rat triphenyl phosphate affects expression ISO RGD:1348814 6480464 triphenyl phosphate affects the expression of SLC12A7 mRNA CTD PMID:37042841 Slc12a7 Rat Triptolide increases expression EXP 6480464 triptolide results in increased expression of SLC12A7 protein CTD PMID:32519852 Slc12a7 Rat valproic acid affects expression ISO RGD:1348814 6480464 Valproic Acid affects the expression of SLC12A7 mRNA CTD PMID:25979313 Slc12a7 Rat valproic acid multiple interactions ISO RGD:1348814 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Slc12a7 Rat valproic acid decreases expression ISO RGD:1348814 6480464 Valproic Acid results in decreased expression of SLC12A7 mRNA; Valproic Acid results in decreased expression more ... CTD PMID:23179753|PMID:26272509|PMID:29501571 Slc12a7 Rat vanadium atom decreases expression ISO RGD:1348814 6480464 Vanadium results in decreased expression of SLC12A7 mRNA CTD PMID:19000753 Slc12a7 Rat vanadium(0) decreases expression ISO RGD:1348814 6480464 Vanadium results in decreased expression of SLC12A7 mRNA CTD PMID:19000753 Slc12a7 Rat vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of SLC12A7 gene CTD PMID:31079544|PMID:31682807
1,2-dimethylhydrazine (ISO) 1-Hydroxypyrene (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dinitrotoluene (EXP) 2,6-dinitrotoluene (EXP) 2-palmitoylglycerol (ISO) 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid (ISO) 4-hydroxyphenyl retinamide (ISO) 4-tert-Octylphenol (EXP) 6-propyl-2-thiouracil (EXP) amphetamine (EXP) antirheumatic drug (ISO) arsane (ISO) arsenic atom (ISO) atrazine (EXP) Azoxymethane (ISO) barium(0) (ISO) benzo[a]pyrene (ISO) beta-lapachone (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) bumetanide (ISO) Butylbenzyl phthalate (ISO) C60 fullerene (EXP) cadmium dichloride (ISO) chromium(6+) (ISO) cisplatin (ISO) Cuprizon (EXP) cyclosporin A (ISO) dextran sulfate (ISO) diazinon (ISO) dibutyl phthalate (EXP,ISO) diethyl phthalate (ISO) diethylstilbestrol (EXP) diisobutyl phthalate (ISO) diisononyl phthalate (ISO) dorsomorphin (ISO) endosulfan (EXP) epoxiconazole (ISO) ethanol (ISO) fenamidone (ISO) fipronil (EXP) flutamide (EXP) folic acid (ISO) FR900359 (ISO) furosemide (ISO) hydrogen cyanide (ISO) leflunomide (ISO) Licochalcone B (ISO) menadione (ISO) methotrexate (ISO) N-methyl-4-phenylpyridinium (ISO) nickel sulfate (ISO) okadaic acid (ISO) oxaliplatin (EXP) p-tert-Amylphenol (EXP) paracetamol (EXP,ISO) perfluorohexanesulfonic acid (ISO) pirinixic acid (ISO) potassium cyanide (ISO) pregnenolone 16alpha-carbonitrile (EXP) propiconazole (ISO) resveratrol (ISO) rotenone (ISO) SB 431542 (ISO) silicon dioxide (ISO) sulforaphane (ISO) sunitinib (ISO) tetrachloromethane (EXP) thioacetamide (EXP) titanium dioxide (ISO) topotecan (EXP) trichlormethiazide (ISO) triphenyl phosphate (ISO) Triptolide (EXP) valproic acid (ISO) vanadium atom (ISO) vanadium(0) (ISO) vinclozolin (EXP)
Slc12a7 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 31,301,243 - 31,382,825 (-) NCBI GRCr8 mRatBN7.2 1 29,472,692 - 29,554,246 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 29,472,692 - 29,554,302 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 29,273,827 - 29,327,212 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 35,273,677 - 35,327,062 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 29,474,455 - 29,527,840 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 32,086,755 - 32,167,950 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 32,086,755 - 32,141,036 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 33,511,432 - 33,592,624 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 30,281,826 - 30,334,183 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 30,283,750 - 30,337,129 (-) NCBI Celera 1 28,120,766 - 28,174,109 (-) NCBI Celera Cytogenetic Map 1 p11 NCBI
SLC12A7 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 5 1,050,384 - 1,155,899 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 5 1,050,384 - 1,112,063 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 5 1,050,499 - 1,112,178 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 5 1,103,489 - 1,165,172 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 5 1,103,499 - 1,165,109 NCBI Celera 5 1,087,603 - 1,137,533 (-) NCBI Celera Cytogenetic Map 5 p15.33 NCBI HuRef 5 1,032,225 - 1,074,697 (-) NCBI HuRef CHM1_1 5 1,050,309 - 1,109,639 (-) NCBI CHM1_1 T2T-CHM13v2.0 5 955,618 - 1,061,601 (-) NCBI T2T-CHM13v2.0
Slc12a7 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 13 73,881,172 - 73,964,873 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 13 73,881,213 - 73,964,873 (+) Ensembl GRCm39 Ensembl GRCm38 13 73,733,052 - 73,816,754 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 13 73,733,094 - 73,816,754 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 13 73,901,145 - 73,954,191 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 13 74,229,699 - 74,282,745 (+) NCBI MGSCv36 mm8 Celera 13 76,093,026 - 76,146,073 (+) NCBI Celera Cytogenetic Map 13 C1 NCBI cM Map 13 40.15 NCBI
Slc12a7 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955504 530,343 - 568,569 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955504 529,183 - 589,728 (-) NCBI ChiLan1.0 ChiLan1.0
SLC12A7 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 4 1,297,648 - 1,358,631 (-) NCBI NHGRI_mPanPan1-v2 PanPan1.1 Ensembl 5 1,094,769 - 1,147,759 (-) Ensembl panpan1.1 panPan2
SLC12A7 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 34 11,411,521 - 11,442,175 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 34 11,411,626 - 11,440,957 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 34 15,916,047 - 15,953,273 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 34 11,306,873 - 11,344,109 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 34 11,278,297 - 11,369,935 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 34 11,357,510 - 11,394,729 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 34 11,337,208 - 11,374,410 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 34 11,548,126 - 11,585,343 (+) NCBI UU_Cfam_GSD_1.0
Slc12a7 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
SLC12A7 (Sus scrofa - pig)
SLC12A7 (Chlorocebus sabaeus - green monkey)
Slc12a7 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 255 Count of miRNA genes: 158 Interacting mature miRNAs: 198 Transcripts: ENSRNOT00000022635 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
631688 Hcas2 Hepatocarcinoma susceptibility QTL 2 3 0.0001 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 5925874 115540829 Rat 1357397 Bw41 Body weight QTL 41 4.19 0.0001 body mass (VT:0001259) body weight (CMO:0000012) 1 22340647 49361612 Rat 1578650 Bmd6 Bone mineral density QTL 6 12.2 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 1 509108 43284926 Rat 1578651 Bmd7 Bone mineral density QTL 7 14.2 femur mineral mass (VT:0010011) compact volumetric bone mineral density (CMO:0001730) 1 509108 43284926 Rat 2313062 Bmd73 Bone mineral density QTL 73 3.9 0.0001 tibia mineral mass (VT:1000283) compact volumetric bone mineral density (CMO:0001730) 1 11481312 82174945 Rat 1554320 Bmd1 Bone mineral density QTL 1 12.2 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 1 509108 86060548 Rat 2313065 Bss67 Bone structure and strength QTL 67 3.1 0.0001 tibia area (VT:1000281) tibia total energy absorbed before break (CMO:0001736) 1 11481312 82174945 Rat 7421626 Bp360 Blood pressure QTL 360 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 4393289 49393289 Rat 1357400 Bw62 Body weight QTL62 4.05 inguinal fat pad mass (VT:0010424) inguinal fat pad weight to body weight ratio (CMO:0001253) 1 22340647 67340647 Rat 2313070 Bss52 Bone structure and strength QTL 52 4.4 0.0001 body length (VT:0001256) body length (CMO:0000013) 1 1 32356093 Rat 1357401 Bw43 Body weight QTL 43 3.75 body mass (VT:0001259) body weight (CMO:0000012) 1 22340647 49361612 Rat 2313069 Bss68 Bone structure and strength QTL 68 2.9 0.0001 tibia size trait (VT:0100001) tibia total energy absorbed before break (CMO:0001736) 1 11481312 82174945 Rat 631495 Bp96 Blood pressure QTL 96 4.52 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 22340647 102268831 Rat 631494 Bp95 Blood pressure QTL 95 40 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 16206210 49268520 Rat 2313075 Bss66 Bone structure and strength QTL 66 3.4 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 1 11481312 82174945 Rat 5684998 Bss101 Bone structure and strength QTL 101 3.6 tibia strength trait (VT:1000284) tibia ultimate force (CMO:0001734) 1 15431621 49361612 Rat 5684999 Bss102 Bone structure and strength QTL 102 5.5 7e-07 tibia strength trait (VT:1000284) tibia stiffness (CMO:0001735) 1 15431621 49361612 Rat 1300167 Hrtrt2 Heart rate QTL 2 4.35 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 1 11481312 75088344 Rat 2313077 Bss69 Bone structure and strength QTL 69 3.5 0.0001 tibia strength trait (VT:1000284) bone polar moment of inertia (CMO:0001558) 1 11481312 82174945 Rat 2317755 Glom22 Glomerulus QTL 22 3.8 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 1 11481482 32355910 Rat 1578756 Iddm22 Insulin dependent diabetes mellitus QTL 22 2.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 11835181 56835181 Rat 631508 Sald1 Serum aldosterone level QTL 1 3.7 blood aldosterone amount (VT:0005346) serum aldosterone level (CMO:0000487) 1 9856001 54856001 Rat 1331785 Rf27 Renal function QTL 27 4.643 urine sodium amount (VT:0006274) urine sodium level (CMO:0000129) 1 28879780 78430678 Rat 2313090 Bmd69 Bone mineral density QTL 69 4.4 0.0001 tibia mineral mass (VT:1000283) compact volumetric bone mineral density (CMO:0001730) 1 1 32356093 Rat 724520 Bp145 Blood pressure QTL 145 2.1 0.0024 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 20784828 65784828 Rat 1558642 Prcr2 Prostate cancer resistance QTL 2 4.3 prostate integrity trait (VT:0010571) area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio (CMO:0000899) 1 20763158 44095856 Rat 2313092 Bmd72 Bone mineral density QTL 72 2.5 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 1 11481312 82174945 Rat 2313097 Bss70 Bone structure and strength QTL 70 3.5 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 1 11481312 82174945 Rat 738020 Pia8 Pristane induced arthritis QTL 8 4.7 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 1 1 65833076 Rat 1600360 Mcs16 Mammary carcinoma susceptibility QTL 16 2.4 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 1 2244390 43433040 Rat 1578669 Bss9 Bone structure and strength QTL 9 6.3 femur morphology trait (VT:0000559) bone trabecular cross-sectional area (CMO:0002311) 1 509108 43284926 Rat 2302038 Pia31 Pristane induced arthritis QTL 31 5.5 0.001 blood autoantibody amount (VT:0003725) serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111) 1 10992065 55992065 Rat 634353 Rends2 Renal damage susceptibility QTL 2 0.05 kidney blood vessel morphology trait (VT:0000530) organ lesion measurement (CMO:0000677) 1 19333571 56983283 Rat 2313053 Bss51 Bone structure and strength QTL 51 3.8 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 1 1 32356093 Rat
D1Rat9
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 1 31,350,043 - 31,350,168 (+) Marker Load Pipeline mRatBN7.2 1 29,521,493 - 29,521,616 (+) MAPPER mRatBN7.2 Rnor_6.0 1 32,135,556 - 32,135,680 NCBI Rnor6.0 Rnor_5.0 1 33,560,233 - 33,560,357 UniSTS Rnor5.0 RGSC_v3.4 1 30,329,603 - 30,329,728 RGD RGSC3.4 RGSC_v3.4 1 30,329,604 - 30,329,728 UniSTS RGSC3.4 RGSC_v3.1 1 30,332,549 - 30,332,673 RGD Celera 1 28,169,528 - 28,169,652 UniSTS RH 3.4 Map 1 347.42 RGD RH 3.4 Map 1 347.42 UniSTS RH 2.0 Map 1 221.4 RGD SHRSP x BN Map 1 15.98 RGD FHH x ACI Map 1 23.2999 RGD Cytogenetic Map 1 p11 UniSTS
D1Cebr11
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 29,515,545 - 29,515,709 (+) MAPPER mRatBN7.2 Rnor_6.0 1 32,129,608 - 32,129,771 NCBI Rnor6.0 Rnor_5.0 1 33,554,285 - 33,554,448 UniSTS Rnor5.0 RGSC_v3.4 1 30,323,656 - 30,323,819 UniSTS RGSC3.4 Celera 1 28,163,580 - 28,163,743 UniSTS Cytogenetic Map 1 p11 UniSTS
D1Cebr12
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 29,506,202 - 29,506,405 (+) MAPPER mRatBN7.2 Rnor_6.0 1 32,120,265 - 32,120,467 NCBI Rnor6.0 Rnor_5.0 1 33,544,942 - 33,545,144 UniSTS Rnor5.0 RGSC_v3.4 1 30,314,313 - 30,314,515 UniSTS RGSC3.4 Celera 1 28,154,237 - 28,154,439 UniSTS Cytogenetic Map 1 p11 UniSTS
RH128389
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 29,472,942 - 29,473,135 (+) MAPPER mRatBN7.2 Rnor_6.0 1 32,087,006 - 32,087,198 NCBI Rnor6.0 Rnor_5.0 1 33,511,683 - 33,511,875 UniSTS Rnor5.0 RGSC_v3.4 1 30,281,055 - 30,281,247 UniSTS RGSC3.4 Celera 1 28,121,017 - 28,121,209 UniSTS Cytogenetic Map 1 p11 UniSTS
RH133369
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 29,472,794 - 29,472,980 (+) MAPPER mRatBN7.2 Rnor_6.0 1 32,086,858 - 32,087,043 NCBI Rnor6.0 Rnor_5.0 1 33,511,535 - 33,511,720 UniSTS Rnor5.0 RGSC_v3.4 1 30,280,907 - 30,281,092 UniSTS RGSC3.4 Celera 1 28,120,869 - 28,121,054 UniSTS Cytogenetic Map 1 p11 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000022635 ⟹ ENSRNOP00000022635
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 29,472,692 - 29,526,073 (-) Ensembl Rnor_6.0 Ensembl 1 32,086,755 - 32,140,137 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000078039 ⟹ ENSRNOP00000074714
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 29,472,692 - 29,554,302 (-) Ensembl Rnor_6.0 Ensembl 1 32,088,259 - 32,141,036 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000081339 ⟹ ENSRNOP00000071618
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 29,472,694 - 29,526,072 (-) Ensembl Rnor_6.0 Ensembl 1 32,086,757 - 32,140,136 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000112535 ⟹ ENSRNOP00000088698
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 29,472,702 - 29,526,095 (-) Ensembl
RefSeq Acc Id:
NM_001013144 ⟹ NP_001013162
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 31,301,243 - 31,354,625 (-) NCBI mRatBN7.2 1 29,472,692 - 29,526,073 (-) NCBI Rnor_6.0 1 32,086,755 - 32,140,137 (-) NCBI Rnor_5.0 1 33,511,432 - 33,592,624 (-) NCBI Celera 1 28,120,766 - 28,174,109 (-) NCBI
Sequence:
GCTCCGGGGCAGCGTGTGGCTGCGAGGGACGCAGAGTCTAACGGAGCCATGCCCACGAACTTTACGGTGGTGCCGGTGGAGGCGCGCGCCGACGGCGCCGGGGACGAAGCTGCTGAGCGCACGGAAGA ACCCGGGTCTCCCGAGAGCGCGGATCCTGCCTGCCCTACGCCGGGAGATGGAAACCCCAGGGAGAACAGCCCATTCATCAATAATGTGGAGGTGGAAAGAGAGAGCTACTTCGAGGGGAAGAACATGG CGCTTTTTGAGGAAGAGATGGACAGCAACCCCATGGTATCATCACTGCTGAACAAGCTGGCCAACTATACCAACCTGAGCCAGGGTGTGGTAGAGCATGAGGAAGATGAGGACAGCCGGAGGCGGGAG ATCAAGGCCCCACGCATGGGCACCTTCATCGGAGTCTACCTACCGTGCCTGCAGAACATCTTGGGTGTAATCCTTTTCCTGCGCCTGACCTGGATTGTGGGGGCGGCTGGCGTTCTGGAGTCCTTCCT CATCGTGGCCATGTGCTGCACCTGTACAATGCTGACAGCCATCTCCATGAGTGCCATCGCTACCAACGGTGTGGTCCCAGCGGGAGGCTCATACTACATGATCTCCCGTTCGCTGGGGCCTGAGTTTG GAGGGGCTGTTGGCCTCTGCTTCTACTTGGGCACAACGTTCGCAGGCGCCATGTACATCCTGGGAACCATCGAGATCTTCCTGACCTACATCTCTCCAAGTGCAGCCATCTTCCAGGCAGAGACAGCA GACGGCGAGGCGGCCGCGCTGCTGAACAACATGCGTGTGTATGGCAGCTGCGCACTGGCGCTCATGGCCGTGGTGGTCTTCGTCGGAGTCAAATATGTCAACAAGCTGGCCCTGGTCTTCTTAGCCTG TGTTGTGCTTTCTATCCTGGCCATCTATGCTGGTGTCATCAAGACAGCCTTCGCCCCACCTGACATCCCGGTCTGCCTTCTAGGGAACCGCACGCTGGCGAATCGCAACTTTGATACCTGTGCCAAAA TGCAGGTTGTCAGCAATGGCACAGTCACCACCGCGCTCTGGCGCCTCTTCTGCAACGGCTCCAGCTTGGGTGCCTCCTGCGATGAGTACTTTGTGCAGAACAATGTCACTGAGATCCAGGGCATTCCT GGTGTGGCCAGTGGTGTCTTCCTGGATAACCTGTGGAGCACGTATTCGGACAAGGGGGCATTTGTGGAAAAGAAGGGCGTGTCCTCGGTGCCTGTGTCCGAGGAGAGCCGGCCTGGTGGATTGCCATA TGTCCTCACAGACATCATGACCTACTTCACCATGCTAGTCGGCATCTACTTCCCCTCCGTAACGGGGATCATGGCAGGATCCAACCGCTCCGGGGACCTCAAAGATGCCCAGAAGTCCATCCCAACAG GGACCATTCTGGCCATTGTGACTACATCTTTCATTTATCTTTCCTGCATTGTGCTGTTTGGGGCCTGCATCGAGGGTGTAGTCTTGCGAGATAAGTTTGGGGAGGCCCTGCAAGGGAACTTGGTCATT GGCATGCTGGCTTGGCCATCTCCCTGGGTCATCGTGATTGGCTCCTTCTTCTCCACCTGTGGTGCTGGCCTGCAGAGCCTAACTGGGGCACCCCGCCTGCTGCAGGCCATTGCACGCGACGGCATCAT CCCCTTCCTGCAGGTGTTTGGCCATGGAAAGGCCAACGGGGAGCCCACGTGGGCCCTGCTGCTCACGGCCCTCATCTGTGAGACCGGCATCCTCATCGCCTCCCTGGACAGCGTGGCTCCCATCCTGT CCATGTTCTTCCTCATGTGCTACATGTTCGTCAACCTGGCCTGTGCTGTTCAGACCCTGCTGCGCACACCCAACTGGCGTCCACGTTTCAAGTTCTACCACTGGACCCTCTCCTTCCTTGGGATGAGT CTCTGCCTTGCGCTCATGTTCATCTGCTCCTGGTACTACGCCCTCTTCGCCATGCTCATCGCGGGCTGCATCTACAAGTACATCGAGTACCGAGGGGCTGAGAAGGAGTGGGGGGATGGCATCAGGGG CCTGTCACTGAATGCTGCCCGCTATGCCCTGCTGCGTGTGGAACATGGGCCCCCACATACCAAGAACTGGAGGCCCCAGGTATTGGTGATGCTGAACCTGGACTCTGAGCAGTGTGTAAAGCACCCCC GCCTGCTGTCCTTCACCTCTCAGCTGAAGGCTGGCAAGGGCCTGACCATCGTGGGATCTGTGCTGGAGGGCACCTACTTAGACAAGCATGTGGAGGCCCAGCGGGCTGAGGAGAATATCCGGTCTCTG ATGAGTGCAGAGAAGATGAAAGGCTTCTGCCAGCTGGTGGTGTCGTCCAACCTGCGAGACGGTGCATCCCACTTGATCCAGTCAGCTGGCCTTGGTGGCATGAAGCACAACACTGTCCTCATGGCCTG GCCAGAGGCTTGGAAGCAGGCAGATAACCCTTTCTCCTGGAAGAACTTTGTGGACACTGTCCGTGACACTACAGCAGCACATCAGGCACTGTTGGTGGCCAAGAACATCGACTTGTTCCCGCAGAACC AGGAGCGCTTCAGCGACGGCAACATCGATGTGTGGTGGATCGTGCACGATGGGGGGATGCTCATGCTTCTGCCGTTCCTGCTGCGCCAGCACAAGGTGTGGCGAAAGTGCCGGATGCGCATCTTCACG GTCGCCCAGGTGGACGATAACAGCATCCAGATGAAGAAGGACCTGCAGATGTTCCTGTACCATCTCAGGATCAGCGCCGAGGTGGAGGTGGTAGAGATGGTTGAAAATGACATTTCTGCATTCACCTA TGAGAAGACGCTAATGATGGAGCAGAGGTCACAGATGCTGAAACAGATGCAGTTGTCAAAGAATGAGCGGGAGAGAGAGGCCCAGCTGATTCACGACAGGAACACTGCATCCCACACCGTAGCAACGG CTAGAACTGAAGCCCCACCAACACCTGACAAAGTGCAGATGACATGGACGAAAGAGAAACTCATTGCAGAGAAACACAGGAACAAGGACACCGGCACATCAGGCTTCAAAGACCTTTTCAGCCTAAAG CCGGACCAGTCCAACGTCAGAAGGATGCATACTGCTGTGAAGCTCAATGGTGTGGTTCTCAACAAGTCCCAGGATGCTCAACTCGTCCTGCTGAATATGCCAGGCCCCCCAAAAAGTCGGCAGGGCGA CGAGAACTACATGGAATTTCTTGAGGTCTTGACCGAAGGGCTGAACAGGGTCCTCCTGGTCAGGGGTGGTGGCCGGGAAGTCATCACCATCTACTCCTAACACCTGAAGCCTGGACACACATGGATGG GGTCAGGACTTCGCGAGCTGCCTGTGACCAGGCTGGGGCTCACCAGGTGCTGCTGACTGATGGCCTACCCTAGCACCTGTTGCCTGGCCAACCAAGATGTTGCAGTGATCCTGGTCACCCTGACACAC ATGGCTTCCCACAGACATAATACTCCGTAGGCTTCCTCCAAGCAGAGGATGCTACATGGGGAGTATCTAGAGCTGTTCTGACAGGAATGGCTCCTTAACATTGTCGTGGGCAACGGTAGGTATACCCA GGGGATCTGGGGCAGCTCTGGCGCCTCTGTACCTTTCACGAACCTGACAGATGAACCAGAACACGTGAACAAGCACACAGTTCCTTGGGGCTAGAATGTCACTGAGCGGTTCTCCATTGGCTTCTGCC TTCTTCGTTCCTTGGAGCATCCCTGATGTGCTTTCTGTACAGTAGGCACACTGAGGACTGTTCACCCTCACGCACACCTCACCTCCTTATTTCCTCCCCGCTCTCCTCAGACACGGCTCAGGGTACCA CTGGAAAGTGACATAGTGTTTACAGGATAGGAGTGGGTCACCATTAGAGCCGGTGGTGCCTGCCAGCTCTGTTCCCATCTGAGTTGATGCCCTAGGAGCTCCTGCAGAGAGAACCTTTGTTCTGCAGG GCTCTCTGCAGTGAGCCCGCGTTCTCTTCTCACGGGAACTCAGTCACTTTACTTCATAAGCACTGAGCTGGGACCTCAAGCGGGTGACTACCGGGAGCCACAGTGTGACAAACAGCAGGAACACTGAG AACTCTGCACATAGTCCATGATGACAGCAAGGCACCTTCCAGAGTGTGAACCATGCACACAGCTTCACATATGACATGCCGTCCCATCCCTCACCCTCCTGGAGAGAACAGCCAGGCCCAGCCCAGTA CCCTCGGCATCGGCAGCCACAGCCCTGGGTCTTTCTGGCTGAGTCTCTTGTCTCCTGCTGTGGAGCCTTGCTCAGCCGGGGCCATGGGCGCCTCTGCACTTTCTAAGGAGCTGACAGATGATTTGCAC TTTACCCTTGGGCATTCTGTTCTGTAGGTCATGGTTTGTTCACAGGCTGTGGGCAACAGCAGTGATCCGTTCCTCACATTGTGTGTGGCATATTTATTTATTTAACCCTCCCTGGGGAAGCTTGATAG AGATAGCTTCTGTGTGGATGCCCCGTGCTGCCAGGCTCTGGGCATCTCTGGCTTCCTCCGAGAGAATCAACCCCGTCCACACTCACGACGTTCTGGTTAGGGTAGAAGCCAAGTTTGCACCTGCACAG TTTCTTCAGACTTTGTTAGGCAGCCAGAGGTAGGCTTGCCAAGTAACTGCTGCCCGGTGTGTGTCCCCATCAGGGTAGTGATTTCCACACCTGCTTTTGACTCAGCACTGGACTTGGCTCAGACTCCT GAGCCCTCGATGTCTAGAGCAGAGCAGGTGGGGCGCTGCTCCCAGCTGTCAGGAATGCCTTGGGCAGGTGGCCCTTTCAGGTTCTGGGTCACTGCTTACAAGAGCTGCCTGTCAAGAGTGTCCAGCCT CCTTATCTCGCAGACTCCGTGTTCCTGGTAACTGTGGCCATTCAGATCAGTTTCATGTTTTCCTTTTTATAGGCTTTTGCCTTTGTATGACTTTGTTAGTAGAAGAGTAAAGTTCTATAAAATATAAA TGTTTAAGGAA
hide sequence
RefSeq Acc Id:
XM_006227789 ⟹ XP_006227851
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 31,301,243 - 31,382,825 (-) NCBI mRatBN7.2 1 29,472,692 - 29,554,245 (-) NCBI Rnor_6.0 1 32,086,755 - 32,167,950 (-) NCBI Rnor_5.0 1 33,511,432 - 33,592,624 (-) NCBI
Sequence:
CCGCTCCCCGAGACCCACGGTCAGCACCGGCAGACCTTCGCATCCAGCAGTCATCGCGGCGCCT GGCGTTCCGACGCCAACATGTCCCAGCGCTTCGTGGTGATCCCAGCACAGAGCGGGACGGGGGACGCGGGACCCAGGGCAGAAGGTGGCAGCGGCGGCAGCCAGCGCCTGTGCTCGGATCCCGACCCC GACCCCGACCCTGACCCCGACCCCGATCCCAGCCTGGCGGCCGCTCTGAAAACACAAGAAGTAGATGCGCTGCCCATTCTGCGCTACTGCCGCGAGCCCAGCCGCTATGGAGATGGAAACCCCAGGGA GAACAGCCCATTCATCAATAATGTGGAGGTGGAAAGAGAGAGCTACTTCGAGGGGAAGAACATGGCGCTTTTTGAGGAAGAGATGGACAGCAACCCCATGGTATCATCACTGCTGAACAAGCTGGCCA ACTATACCAACCTGAGCCAGGGTGTGGTAGAGCATGAGGAAGATGAGGACAGCCGGAGGCGGGAGATCAAGGCCCCACGCATGGGCACCTTCATCGGAGTCTACCTACCGTGCCTGCAGAACATCTTG GGTGTAATCCTTTTCCTGCGCCTGACCTGGATTGTGGGGGCGGCTGGCGTTCTGGAGTCCTTCCTCATCGTGGCCATGTGCTGCACCTGTACAATGCTGACAGCCATCTCCATGAGTGCCATCGCTAC CAACGGTGTGGTCCCAGCGGGAGGCTCATACTACATGATCTCCCGTTCGCTGGGGCCTGAGTTTGGAGGGGCTGTTGGCCTCTGCTTCTACTTGGGCACAACGTTCGCAGGCGCCATGTACATCCTGG GAACCATCGAGATCTTCCTGACCTACATCTCTCCAAGTGCAGCCATCTTCCAGGCAGAGACAGCAGACGGCGAGGCGGCCGCGCTGCTGAACAACATGCGTGTGTATGGCAGCTGCGCACTGGCGCTC ATGGCCGTGGTGGTCTTCGTCGGAGTCAAATATGTCAACAAGCTGGCCCTGGTCTTCTTAGCCTGTGTTGTGCTTTCTATCCTGGCCATCTATGCTGGTGTCATCAAGACAGCCTTCGCCCCACCTGA CATCCCGGTCTGCCTTCTAGGGAACCGCACGCTGGCGAATCGCAACTTTGATACCTGTGCCAAAATGCAGGTTGTCAGCAATGGCACAGTCACCACCGCGCTCTGGCGCCTCTTCTGCAACGGCTCCA GCTTGGGTGCCTCCTGCGATGAGTACTTTGTGCAGAACAATGTCACTGAGATCCAGGGCATTCCTGGTGTGGCCAGTGGTGTCTTCCTGGATAACCTGTGGAGCACGTATTCGGACAAGGGGGCATTT GTGGAAAAGAAGGGCGTGTCCTCGGTGCCTGTGTCCGAGGAGAGCCGGCCTGGTGGATTGCCATATGTCCTCACAGACATCATGACCTACTTCACCATGCTAGTCGGCATCTACTTCCCCTCCGTAAC GGGGATCATGGCAGGATCCAACCGCTCCGGGGACCTCAAAGATGCCCAGAAGTCCATCCCAACAGGGACCATTCTGGCCATTGTGACTACATCTTTCATTTATCTTTCCTGCATTGTGCTGTTTGGGG CCTGCATCGAGGGTGTAGTCTTGCGAGATAAGTTTGGGGAGGCCCTGCAAGGGAACTTGGTCATTGGCATGCTGGCTTGGCCATCTCCCTGGGTCATCGTGATTGGCTCCTTCTTCTCCACCTGTGGT GCTGGCCTGCAGAGCCTAACTGGGGCACCCCGCCTGCTGCAGGCCATTGCACGCGACGGCATCATCCCCTTCCTGCAGGTGTTTGGCCATGGAAAGGCCAACGGGGAGCCCACGTGGGCCCTGCTGCT CACGGCCCTCATCTGTGAGACCGGCATCCTCATCGCCTCCCTGGACAGCGTGGCTCCCATCCTGTCCATGTTCTTCCTCATGTGCTACATGTTCGTCAACCTGGCCTGTGCTGTTCAGACCCTGCTGC GCACACCCAACTGGCGTCCACGTTTCAAGTTCTACCACTGGACCCTCTCCTTCCTTGGGATGAGTCTCTGCCTTGCGCTCATGTTCATCTGCTCCTGGTACTACGCCCTCTTCGCCATGCTCATCGCG GGCTGCATCTACAAGTACATCGAGTACCGAGGGGCTGAGAAGGAGTGGGGGGATGGCATCAGGGGCCTGTCACTGAATGCTGCCCGCTATGCCCTGCTGCGTGTGGAACATGGGCCCCCACATACCAA GAACTGGAGGCCCCAGGTATTGGTGATGCTGAACCTGGACTCTGAGCAGTGTGTAAAGCACCCCCGCCTGCTGTCCTTCACCTCTCAGCTGAAGGCTGGCAAGGGCCTGACCATCGTGGGATCTGTGC TGGAGGGCACCTACTTAGACAAGCATGTGGAGGCCCAGCGGGCTGAGGAGAATATCCGGTCTCTGATGAGTGCAGAGAAGATGAAAGGCTTCTGCCAGCTGGTGGTGTCGTCCAACCTGCGAGACGGT GCATCCCACTTGATCCAGTCAGCTGGCCTTGGTGGCATGAAGCACAACACTGTCCTCATGGCCTGGCCAGAGGCTTGGAAGCAGGCAGATAACCCTTTCTCCTGGAAGAACTTTGTGGACACTGTCCG TGACACTACAGCAGCACATCAGGCACTGTTGGTGGCCAAGAACATCGACTTGTTCCCGCAGAACCAGGAGCGCTTCAGCGACGGCAACATCGATGTGTGGTGGATCGTGCACGATGGGGGGATGCTCA TGCTTCTGCCGTTCCTGCTGCGCCAGCACAAGGTGTGGCGAAAGTGCCGGATGCGCATCTTCACGGTCGCCCAGGTGGACGATAACAGCATCCAGATGAAGAAGGACCTGCAGATGTTCCTGTACCAT CTCAGGATCAGCGCCGAGGTGGAGGTGGTAGAGATGGTTGAAAATGACATTTCTGCATTCACCTATGAGAAGACGCTAATGATGGAGCAGAGGTCACAGATGCTGAAACAGATGCAGTTGTCAAAGAA TGAGCGGGAGAGAGAGGCCCAGCTGATTCACGACAGGAACACTGCATCCCACACCGTAGCAACGGCTAGAACTGAAGCCCCACCAACACCTGACAAAGTGCAGATGACATGGACGAAAGAGAAACTCA TTGCAGAGAAACACAGGAACAAGGACACCGGCACATCAGGCTTCAAAGACCTTTTCAGCCTAAAGCCGGACCAGTCCAACGTCAGAAGGATGCATACTGCTGTGAAGCTCAATGGTGTGGTTCTCAAC AAGTCCCAGGATGCTCAACTCGTCCTGCTGAATATGCCAGGCCCCCCAAAAAGTCGGCAGGGCGACGAGAACTACATGGAATTTCTTGAGGTCTTGACCGAAGGGCTGAACAGGGTCCTCCTGGTCAG GGGTGGTGGCCGGGAAGTCATCACCATCTACTCCTAACACCTGAAGCCTGGACACACATGGATGGGGTCAGGACTTCGCGAGCTGCCTGTGACCAGGCTGGGGCTCACCAGGTGCTGCTGACTGATGG CCTACCCTAGCACCTGTTGCCTGGCCAACCAAGATGTTGCAGTGATCCTGGTCACCCTGACACACATGGCTTCCCACAGACATAATACTCCGTAGGCTTCCTCCAAGCAGAGGATGCTACATGGGGAG TATCTAGAGCTGTTCTGACAGGAATGGCTCCTTAACATTGTCGTGGGCAACGGTAGGTATACCCAGGGGATCTGGGGCAGCTCTGGCGCCTCTGTACCTTTCACGAACCTGACAGATGAACCAGAACA CGTGAACAAGCACACAGTTCCTTGGGGCTAGAATGTCACTGAGCGGTTCTCCATTGGCTTCTGCCTTCTTCGTTCCTTGGAGCATCCCTGATGTGCTTTCTGTACAGTAGGCACACTGAGGACTGTTC ACCCTCACGCACACCTCACCTCCTTATTTCCTCCCCGCTCTCCTCAGACACGGCTCAGGGTACCACTGGAAAGTGACATAGTGTTTACAGGATAGGAGTGGGTCACCATTAGAGCCGGTGGTGCCTGC CAGCTCTGTTCCCATCTGAGTTGATGCCCTAGGAGCTCCTGCAGAGAGAACCTTTGTTCTGCAGGGCTCTCTGCAGTGAGCCCGCGTTCTCTTCTCACGGGAACTCAGTCACTTTACTTCATAAGCAC TGAGCTGGGACCTCAAGCGGGTGACTACCGGGAGCCACAGTGTGACAAACAGCAGGAACACTGAGAACTCTGCACATAGTCCATGATGACAGCAAGGCACCTTCCAGAGTGTGAACCATGCACACAGC TTCACATATGACATGCCGTCCCATCCCTCACCCTCCTGGAGAGAACAGCCAGGCCCAGCCCAGTACCCTCGGCATCGGCAGCCACAGCCCTGGGTCTTTCTGGCTGAGTCTCTTGTCTCCTGCTGTGG AGCCTTGCTCAGCCGGGGCCATGGGCGCCTCTGCACTTTCTAAGGAGCTGACAGATGATTTGCACTTTACCCTTGGGCATTCTGTTCTGTAGGTCATGGTTTGTTCACAGGCTGTGGGCAACAGCAGT GATCCGTTCCTCACATTGTGTGTGGCATATTTATTTATTTAACCCTCCCTGGGGAAGCTTGATAGAGATAGCTTCTGTGTGGATGCCCCGTGCTGCCAGGCTCTGGGCATCTCTGGCTTCCTCCGAGA GAATCAACCCCGTCCACACTCACGACGTTCTGGTTAGGGTAGAAGCCAAGTTTGCACCTGCACAGTTTCTTCAGACTTTGTTAGGCAGCCAGAGGTAGGCTTGCCAAGTAACTGCTGCCCGGTGTGTG TCCCCATCAGGGTAGTGATTTCCACACCTGCTTTTGACTCAGCACTGGACTTGGCTCAGACTCCTGAGCCCTCGATGTCTAGAGCAGAGCAGGTGGGGCGCTGCTCCCAGCTGTCAGGAATGCCTTGG GCAGGTGGCCCTTTCAGGTTCTGGGTCACTGCTTACAAGAGCTGCCTGTCAAGAGTGTCCAGCCTCCTTATCTCGCAGACTCCGTGTTCCTGGTAACTGTGGCCATTCAGATCAGTTTCATGTTTTCC TTTTTATAGGCTTTTGCCTTTGTATGACTTTGTTAGTAGAAGAGTAAAGTTCTATAAAATATAAATGTTTAAGGAA
hide sequence
RefSeq Acc Id:
XM_063288386 ⟹ XP_063144456
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 31,301,243 - 31,382,805 (-) NCBI
RefSeq Acc Id:
XM_063288392 ⟹ XP_063144462
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 31,301,243 - 31,354,918 (-) NCBI
RefSeq Acc Id:
NP_001013162 ⟸ NM_001013144
- UniProtKB:
Q6TUA1 (UniProtKB/Swiss-Prot), Q6T7Y5 (UniProtKB/Swiss-Prot), Q6TUA2 (UniProtKB/Swiss-Prot), Q5RK27 (UniProtKB/Swiss-Prot), A6JUW3 (UniProtKB/TrEMBL), A0A8L2QBZ1 (UniProtKB/TrEMBL)
- Sequence:
MPTNFTVVPVEARADGAGDEAAERTEEPGSPESADPACPTPGDGNPRENSPFINNVEVERESYFEGKNMALFEEEMDSNPMVSSLLNKLANYTNLSQGVVEHEEDEDSRRREIKAPRMGTFIGVYLPC LQNILGVILFLRLTWIVGAAGVLESFLIVAMCCTCTMLTAISMSAIATNGVVPAGGSYYMISRSLGPEFGGAVGLCFYLGTTFAGAMYILGTIEIFLTYISPSAAIFQAETADGEAAALLNNMRVYGS CALALMAVVVFVGVKYVNKLALVFLACVVLSILAIYAGVIKTAFAPPDIPVCLLGNRTLANRNFDTCAKMQVVSNGTVTTALWRLFCNGSSLGASCDEYFVQNNVTEIQGIPGVASGVFLDNLWSTYS DKGAFVEKKGVSSVPVSEESRPGGLPYVLTDIMTYFTMLVGIYFPSVTGIMAGSNRSGDLKDAQKSIPTGTILAIVTTSFIYLSCIVLFGACIEGVVLRDKFGEALQGNLVIGMLAWPSPWVIVIGSF FSTCGAGLQSLTGAPRLLQAIARDGIIPFLQVFGHGKANGEPTWALLLTALICETGILIASLDSVAPILSMFFLMCYMFVNLACAVQTLLRTPNWRPRFKFYHWTLSFLGMSLCLALMFICSWYYALF AMLIAGCIYKYIEYRGAEKEWGDGIRGLSLNAARYALLRVEHGPPHTKNWRPQVLVMLNLDSEQCVKHPRLLSFTSQLKAGKGLTIVGSVLEGTYLDKHVEAQRAEENIRSLMSAEKMKGFCQLVVSS NLRDGASHLIQSAGLGGMKHNTVLMAWPEAWKQADNPFSWKNFVDTVRDTTAAHQALLVAKNIDLFPQNQERFSDGNIDVWWIVHDGGMLMLLPFLLRQHKVWRKCRMRIFTVAQVDDNSIQMKKDLQ MFLYHLRISAEVEVVEMVENDISAFTYEKTLMMEQRSQMLKQMQLSKNEREREAQLIHDRNTASHTVATARTEAPPTPDKVQMTWTKEKLIAEKHRNKDTGTSGFKDLFSLKPDQSNVRRMHTAVKLN GVVLNKSQDAQLVLLNMPGPPKSRQGDENYMEFLEVLTEGLNRVLLVRGGGREVITIYS
hide sequence
RefSeq Acc Id:
XP_006227851 ⟸ XM_006227789
- Peptide Label:
isoform X3
- UniProtKB:
A0A0G2K8S1 (UniProtKB/TrEMBL)
- Sequence:
MSQRFVVIPAQSGTGDAGPRAEGGSGGSQRLCSDPDPDPDPDPDPDPSLAAALKTQEVDALPIL RYCREPSRYGDGNPRENSPFINNVEVERESYFEGKNMALFEEEMDSNPMVSSLLNKLANYTNLSQGVVEHEEDEDSRRREIKAPRMGTFIGVYLPCLQNILGVILFLRLTWIVGAAGVLESFLIVAMC CTCTMLTAISMSAIATNGVVPAGGSYYMISRSLGPEFGGAVGLCFYLGTTFAGAMYILGTIEIFLTYISPSAAIFQAETADGEAAALLNNMRVYGSCALALMAVVVFVGVKYVNKLALVFLACVVLSI LAIYAGVIKTAFAPPDIPVCLLGNRTLANRNFDTCAKMQVVSNGTVTTALWRLFCNGSSLGASCDEYFVQNNVTEIQGIPGVASGVFLDNLWSTYSDKGAFVEKKGVSSVPVSEESRPGGLPYVLTDI MTYFTMLVGIYFPSVTGIMAGSNRSGDLKDAQKSIPTGTILAIVTTSFIYLSCIVLFGACIEGVVLRDKFGEALQGNLVIGMLAWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIARDGIIPFLQV FGHGKANGEPTWALLLTALICETGILIASLDSVAPILSMFFLMCYMFVNLACAVQTLLRTPNWRPRFKFYHWTLSFLGMSLCLALMFICSWYYALFAMLIAGCIYKYIEYRGAEKEWGDGIRGLSLNA ARYALLRVEHGPPHTKNWRPQVLVMLNLDSEQCVKHPRLLSFTSQLKAGKGLTIVGSVLEGTYLDKHVEAQRAEENIRSLMSAEKMKGFCQLVVSSNLRDGASHLIQSAGLGGMKHNTVLMAWPEAWK QADNPFSWKNFVDTVRDTTAAHQALLVAKNIDLFPQNQERFSDGNIDVWWIVHDGGMLMLLPFLLRQHKVWRKCRMRIFTVAQVDDNSIQMKKDLQMFLYHLRISAEVEVVEMVENDISAFTYEKTLM MEQRSQMLKQMQLSKNEREREAQLIHDRNTASHTVATARTEAPPTPDKVQMTWTKEKLIAEKHRNKDTGTSGFKDLFSLKPDQSNVRRMHTAVKLNGVVLNKSQDAQLVLLNMPGPPKSRQGDENYME FLEVLTEGLNRVLLVRGGGREVITIYS
hide sequence
Ensembl Acc Id:
ENSRNOP00000074714 ⟸ ENSRNOT00000078039
Ensembl Acc Id:
ENSRNOP00000071618 ⟸ ENSRNOT00000081339
Ensembl Acc Id:
ENSRNOP00000022635 ⟸ ENSRNOT00000022635
Ensembl Acc Id:
ENSRNOP00000088698 ⟸ ENSRNOT00000112535
RefSeq Acc Id:
XP_063144456 ⟸ XM_063288386
- Peptide Label:
isoform X1
- UniProtKB:
A0A0G2K8S1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063144462 ⟸ XM_063288392
- Peptide Label:
isoform X2
- UniProtKB:
A0A8I6A5L8 (UniProtKB/TrEMBL)
RGD ID: 13689565
Promoter ID: EPDNEW_R90
Type: initiation region
Name: Slc12a7_1
Description: solute carrier family 12 member 7
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 1 32,140,151 - 32,140,211 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2016-02-25
Slc12a7
solute carrier family 12 member 7
Slc12a7
solute carrier family 12 (potassium/chloride transporter), member 7
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2013-08-02
Slc12a7
solute carrier family 12 (potassium/chloride transporter), member 7
Slc12a7
solute carrier family 12 (potassium/chloride transporters), member 7
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-09-19
Slc12a7
solute carrier family 12 (potassium/chloride transporters), member 7
Slc12a7
solute carrier family 12, member 7
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-03-07
Slc12a7
solute carrier family 12, member 7
Slc12a7
solute carrier family 12 (potassium/chloride transporters), member 7
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2005-11-17
Slc12a7
solute carrier family 12 (potassium/chloride transporters), member 7
Symbol and Name updated
1299863
APPROVED
2005-07-29
LOC308069
K-Cl cotransporter KCC4
Symbol and Name status set to provisional
70820
PROVISIONAL